CRYOPORT, INC. Unrealized Gain (Loss) on Investments
CRYOPORT, INC. (CYRX) reported Unrealized Gain (Loss) on Investments of -$469.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-08-06
- CRYOPORT, INC. unrealized gain (loss) on investments for the quarter ending 2026-06-30 was $593.00K.
- CRYOPORT, INC. unrealized gain (loss) on investments for the quarter ending 2026-03-31 was -$1.06M, a 261.15% decline year-over-year.
- CRYOPORT, INC. unrealized gain (loss) on investments for the quarter ending 2025-12-31 was -$157.00K.
- CRYOPORT, INC. unrealized gain (loss) on investments for the quarter ending 2025-09-30 was $1.05M, a 57.51% decline year-over-year.
- CRYOPORT, INC. unrealized gain (loss) on investments for fiscal 2025 was $1.51M.
- CRYOPORT, INC. unrealized gain (loss) on investments for fiscal 2024 was -$899.00K, a 168.73% decline from fiscal 2023.
- CRYOPORT, INC. unrealized gain (loss) on investments for fiscal 2023 was $1.31M.
- CRYOPORT, INC. unrealized gain (loss) on investments for fiscal 2022 was -$11.41M.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 3 month as first filed | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 6 month as first filed | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 9 month as first filed | Unrealized Gain (Loss) on Investments 12 month | Unrealized Gain (Loss) on Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $593.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$469.00K 10-Q · filed 2026-08-06 | -$626.00K derived: sum of 3 quarters · filed 2026-08-06 | $424.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$1.06M 10-Q · filed 2026-05-05 | -$1.22M derived: sum of 2 quarters · filed 2026-05-05 | -$169.00K derived: sum of 3 quarters · filed 2026-05-05 | -$215.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $893.00K derived: sum of 2 quarters · filed 2026-03-05 | $847.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.51M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.00M derived: sum of 2 quarters · filed 2026-08-06 | $1.66M 10-Q · filed 2025-11-06 | -$681.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $613.00K 10-Q · filed 2026-08-06 | -$1.73M derived: sum of 3 quarters · filed 2026-08-06 | $740.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $659.00K 10-Q · filed 2026-05-05 | -$1.69M derived: sum of 2 quarters · filed 2026-05-05 | $786.00K derived: sum of 3 quarters · filed 2026-05-05 | $438.00K derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $127.00K derived: sum of 2 quarters · filed 2026-03-05 | -$221.00K derived: sum of 3 quarters · filed 2026-03-05 | -$899.00K 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | $2.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.12M derived: sum of 2 quarters · filed 2025-11-06 | $1.45M 10-Q · filed 2025-11-06 | $5.01M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-06-30 | -$348.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.03M 10-Q · filed 2025-08-12 | $2.54M derived: sum of 3 quarters · filed 2026-03-05 | $177.00K derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-03-31 | -$678.00K 10-Q · filed 2025-05-08 | $2.88M derived: sum of 2 quarters · filed 2026-03-05 | $525.00K derived: sum of 3 quarters · filed 2026-03-05 | -$880.00K derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2023-12-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $1.20M derived: sum of 2 quarters · filed 2026-03-05 | -$202.00K derived: sum of 3 quarters · filed 2026-03-05 | $1.31M 10-K · filed 2026-03-05 | ||||
| 2023-09-30 | -$2.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$3.77M derived: sum of 2 quarters · filed 2024-11-07 | -$2.25M 10-Q · filed 2024-11-07 | -$1.23M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-06-30 | -$1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $105.00K 10-Q · filed 2024-08-08 | $1.14M derived: sum of 3 quarters · filed 2025-03-07 | -$2.75M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-03-31 | $1.51M 10-Q · filed 2024-05-08 | $2.54M derived: sum of 2 quarters · filed 2025-03-07 | -$1.34M derived: sum of 3 quarters · filed 2025-03-07 | -$4.99M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2022-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$2.85M derived: sum of 2 quarters · filed 2025-03-07 | -$6.50M derived: sum of 3 quarters · filed 2025-03-07 | -$11.41M 10-K · filed 2025-03-07 | ||||
| 2022-09-30 | -$3.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$7.53M derived: sum of 2 quarters · filed 2023-11-09 | -$12.44M 10-Q · filed 2023-11-09 | -$13.51M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-06-30 | -$3.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$8.56M 10-Q · filed 2023-08-09 | -$9.63M derived: sum of 3 quarters · filed 2024-03-13 | -$9.79M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-03-31 | -$4.91M 10-Q · filed 2023-05-04 | -$5.99M derived: sum of 2 quarters · filed 2024-03-13 | -$6.14M derived: sum of 3 quarters · filed 2024-03-13 | -$6.03M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2021-12-31 | -$1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$1.23M derived: sum of 2 quarters · filed 2024-03-13 | -$1.12M derived: sum of 3 quarters · filed 2024-03-13 | -$1.39M 10-K · filed 2024-03-13 | ||||
| 2021-09-30 | -$152.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$45.00K derived: sum of 2 quarters · filed 2022-11-04 | -$308.00K 10-Q · filed 2022-11-04 | $99.00K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$156.00K 10-Q · filed 2022-08-04 | $251.00K derived: sum of 3 quarters · filed 2023-02-28 | $352.00K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | -$263.00K 10-Q · filed 2022-05-05 | $144.00K derived: sum of 2 quarters · filed 2023-02-28 | $245.00K derived: sum of 3 quarters · filed 2023-02-28 | $438.00K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $407.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $508.00K derived: sum of 2 quarters · filed 2023-02-28 | $701.00K derived: sum of 3 quarters · filed 2023-02-28 | $845.00K 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $101.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $294.00K derived: sum of 2 quarters · filed 2021-11-04 | $438.00K 10-Q · filed 2021-11-04 | $437.76K 10-Q · filed 2020-11-06 | $423.85K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | $193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $337.00K 10-Q · filed 2021-08-06 | $336.58K 10-Q · filed 2020-08-10 | $322.85K derived: sum of 3 quarters · filed 2022-02-28 | $159.65K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $144.00K 10-Q · filed 2021-05-06 | $144.41K 10-Q · filed 2020-05-08 | $129.85K derived: sum of 2 quarters · filed 2022-02-28 | -$33.35K derived: sum of 3 quarters · filed 2022-02-28 | $10.46K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | -$14.15K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$177.35K derived: sum of 2 quarters · filed 2022-02-28 | -$133.54K derived: sum of 3 quarters · filed 2022-02-28 | -$102.00K 10-K · filed 2022-02-28 | -$101.67K 10-K · filed 2020-03-10 | |||
| 2019-09-30 | -$163.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$119.39K derived: sum of 2 quarters · filed 2020-11-06 | -$87.85K 10-Q · filed 2020-11-06 | -$104.08K derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | $43.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $75.35K 10-Q · filed 2020-08-10 | $59.12K derived: sum of 3 quarters · filed 2020-08-10 | $59.12K derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $31.55K 10-Q · filed 2020-05-08 | $15.31K derived: sum of 2 quarters · filed 2020-05-08 | $15.31K derived: sum of 3 quarters · filed 2020-05-08 | $15.31K derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | -$16.23K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$16.23K derived: sum of 2 quarters · filed 2020-03-10 | -$16.23K derived: sum of 3 quarters · filed 2020-03-10 | -$16.23K 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | $0.00 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |